Need professional-grade analysis? Visit stockanalysis.com
$15.06B
80.04
N/A
N/A
Fujian Haixi Pharms Co Ltd (2637) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at HKD195.20, up 3.06% from the previous close.
Over the past year, 2637 has traded between a low of HKD101.50 and a high of HKD206.00. The stock has gained 87.3% over this period. It is currently 5.2% below its 52-week high.
Fujian Haixi Pharms Co Ltd has a market capitalization of $15.06B, with a price-to-earnings ratio of 80.04.
Fujian Haixi Pharmaceuticals Co., Ltd. manufactures and sells pharmaceutical drugs in China. The company offers drugs for oncology, ophthalmology, digestion, cardiovascular, endocrine, and nervous systems, and inflammation. It sells its products through retail pharmacies, online pharmacies, and internet medical platforms. The company was incorporated in 2012 and is based in Fuzhou, China.
Side-by-side comparison against top Healthcare peers.